Intracranial Self-Administration in Frontal Cortex
behavioralratnot specified
Objective: To assess drug reward substrates by having rats learn to lever-press for microinjections of phencyclidine, MK-801, or CPP into frontal cortex and determine if rewarding actions are dopamine-dependent
Materials & Equipment Checklist
7 items1 from ConductScience
Gather these items before starting the experiment. Check off items as you prepare.
Equipment2
not specified • not specified • not specified • not specified
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
View Abstract
Rats learned to lever-press when such behavior was reinforced by microinjections of phencyclidine (PCP) directly into the ventromedial (shell) region of nucleus accumbens, indicating that the drug has direct rewarding actions in that region. Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801) or 3-((±)2-carboxypiperazin-4yl)propyl-1-phosphate (CPP), drugs known to block NMDA receptor function but not dopamine uptake, into the same region. Each drug was ineffective or markedly less effective when injected at a slightly more dorsal and lateral site in the core of nucleus accumbens. Self-administration of PCP, MK-801, or CPP directly into nucleus accumbens was not altered by co-infusion of a dose of the dopamine antagonist sulpiride that effectively blocked intracranial self-administration of the dopamine uptake inhibitor nomifensine, suggesting that the rewarding actions of the NMDA receptor antagonists are not dopamine-dependent. Rats also developed lever-pressing habits when PCP, MK-801, and CPP were each microinjected directly into frontal cortex, a region previously associated with the rewarding actions of cocaine but not nomifensine. Thus nucleus accumbens and frontal cortex are each potential substrates for the rewarding properties of PCP and related drugs, and the ability of these drugs to disrupt NMDA receptor function seems sufficient to account for their rewarding actions. When considered with independent evidence, the present results suggest a model of drug reward within which the critical event is inhibition of medium spiny neurons in nucleus accumbens.
Protocol Steps
1
Establish lever-pressing behavior with PCP reinforcement
Rats learn to lever-press when behavior is reinforced by microinjections of phencyclidine directly into the ventromedial (shell) region of nucleus accumbens
not specifiednot specified
Note: This demonstrates PCP has direct rewarding actions in nucleus accumbens shell
View evidence from paper
“Rats learned to lever-press when such behavior was reinforced by microinjections of phencyclidine (PCP) directly into the ventromedial (shell) region of nucleus accumbens”
2
Test MK-801 reinforcement in nucleus accumbens shell
Separate group of rats learns to lever-press when reinforced with microinjections of dizocilpine (MK-801) into nucleus accumbens shell
not specifiednot specified
Note: MK-801 blocks NMDA receptor function but not dopamine uptake
View evidence from paper
“Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801)”
3
Test CPP reinforcement in nucleus accumbens shell
Separate group of rats learns to lever-press when reinforced with microinjections of CPP into nucleus accumbens shell
not specifiednot specified
Note: CPP blocks NMDA receptor function but not dopamine uptake
View evidence from paper
“Separate groups of rats learned to lever-press when reinforced with microinjections of dizocilpine (MK-801) or 3-((±)2-carboxypiperazin-4yl)propyl-1-phosphate (CPP)”
4
Test drug effectiveness at dorsal and lateral nucleus accumbens core site
Test PCP, MK-801, and CPP at a slightly more dorsal and lateral site in the core of nucleus accumbens to determine regional specificity
not specifiednot specified
Note: Each drug was ineffective or markedly less effective at this site compared to shell
View evidence from paper
“Each drug was ineffective or markedly less effective when injected at a slightly more dorsal and lateral site in the core of nucleus accumbens”
5
Test dopamine-dependence with sulpiride co-infusion
Co-infuse sulpiride (dopamine antagonist) with PCP, MK-801, or CPP into nucleus accumbens to test if rewarding actions are dopamine-dependent
not specifiednot specified
Note: Sulpiride dose was effective at blocking nomifensine self-administration but did not alter NMDA antagonist self-administration
View evidence from paper
“Self-administration of PCP, MK-801, or CPP directly into nucleus accumbens was not altered by co-infusion of a dose of the dopamine antagonist sulpiride that effectively blocked intracranial self-administration of the dopamine uptake inhibitor nomifensine”
6
Test PCP, MK-801, and CPP reinforcement in frontal cortex
Rats develop lever-pressing habits when PCP, MK-801, and CPP are each microinjected directly into frontal cortex
not specifiednot specified
Note: Frontal cortex is a region previously associated with rewarding actions of cocaine but not nomifensine
View evidence from paper
“Rats also developed lever-pressing habits when PCP, MK-801, and CPP were each microinjected directly into frontal cortex”
Subjects / Specimens
Species
rat
Strain
not specified
Age
not specified
Sex
unknown
Weight
not specified
Multiple groups tested with different drugs and injection sites